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Mutations at multiple sites within the simian virus 40 (SV40) early region yield large T antigens which
interfere trans dominantly with the replicative activities of wild-type T antigen. A series of experiments were
conducted to study possible mechanisms of interference with SV40 DNA replication caused by these mutant T
antigens. First, the levels of wild-type T antigen expression in cells cotransfected with wild-type and mutant
SV40 DNAs were examined; approximately equal levels of wild-type T antigen were seen, regardless of whether
the cotransfected mutant was trans dominant or not. Second, double mutants that contained the mutation of
inA2827, a strong trans-dominant mutation with a 12-bp linker inserted at the position encoding amino acid
520, and various mutations in other parts of the large-T-antigen coding region were constructed. The
trans-dominant interference of inA2827 was not affected by second mutations within the p105Rb binding site or
the amino or carboxy terminus of large T antigen. Mutation of the nuclear localization signal partially reduced
the trans dominance of inA2827. The large T antigen of mutant inA2815 contains an insertion of 4 amino acids
at position 168 of large T; this T antigen fails to bind SV40 DNA but is not trans dominant for DNA replication.
The double mutant containing the mutations of both inA2815 and inA2827 was not trans dominant. The large
T antigen of dlA2433 lacks amino acids 587 to 589, was unstable, and failed to bind p53. Combining the
dIA2433 mutation with the inA2827 mutation also reversed the trans dominance completely, but the effect of the
dlA2433 mutation on trans dominance can be explained by the instability of this double mutant protein. In
addition, we examined several mutants with conservative point mutations in the DNA binding domain and
found that most of them were not trans dominant. The implications of the results of these experiments on
possible mechanisms of trans dominance are discussed.
Simian virus 40 (SV40) large T antigen is a multifunctional
nuclear phosphoprotein. Within infected cells, it is found in
both monomeric and oligomeric forms and with a diverse
range of posttranslational modifications, including phosphor-
ylation (52), glycosylation (30), and ADP ribosylation (25). It
plays essential roles in lytic infection and in immortalization
and malignant transformation of nonpermissive cells by
SV40. Large T antigen binds DNA both specifically and
nonspecifically (8, 68) and has helicase and ATPase activities
(29, 62). ATP binding and hydrolysis change the conforma-
tion and oligomerization states of large T antigen (4, 6, 41).
Since not all T-antigen molecules contain the same modi-
fications, there are multiple species of T antigen within
infected cells, and different species of T antigen may have
different biological and biochemical activities (5). For exam-
ple, phosphorylation of certain sites on T antigen regulates
its activity in DNA replication (42, 53), but current under-
standing of the role of these various modifications is incom-
plete. Large T antigen associates with a number of cellular
proteins: p53 (34), the retinoblastoma susceptibility gene
product, p105RI (15), a cellular protein related to p105Rh
with a molecular weight of 107,000 to 120,000 (17, 18), DNA
polymerase x (16, 21, 57), transcription factor AP-2 (44),
cellular heat shock protein hsp73 (51), and probably others.
T antigen causes immortalization of primary rodent cell
cultures (66, 67) and malignant transformation of both pri-
mary cultures and established cell lines (33, 65). Interaction
of T antigen with host proteins, including p53 and p105Rh,
* Corresponding author.
the products of two tumor suppressor genes, probably plays
essential roles in immortalization and transformation. T
antigen also transactivates a number of viral and cellular
genes (7, 32, 58). In addition, large T antigen can induce host
cell DNA synthesis in quiescent cells (10, 59).
During the lytic infection by SV40, large T antigen initiates
viral DNA replication by binding to a palindromic sequence
within the origin of DNA replication (36, 63, 64) and unwind-
ing the double-stranded DNA bidirectionally from the origin
(for a review, see reference 3). Large T antigen is the only
viral protein required for viral DNA replication (64). DNA
binding and ATPase and helicase activities of large T antigen
are essential for viral DNA replication (1, 14) and must be
contained within a single T-antigen monomer. The interac-
tions between T antigen and cellular proteins involved in
viral DNA replication are crucial for initiation and elonga-
tion of SV40 DNA replication (3, 47).
A number of mutant large T antigens were found previ-
ously to interfere with SV40 DNA replication catalyzed by
wild-type T antigen in vivo (19, 75) and in vitro (63). These
have been called trans-dominant mutants. Mutations causing
this trans-dominant effect on DNA replication were located
at various sites throughout much of the T-antigen coding
region and included mutations within the DNA binding and
ATP binding and ATPase domains. The degree of inhibition
of DNA replication varied among the mutants and ranged
from 50% to greater than 90%.
In this article, we present experiments designed to inves-
tigate further the dominant negative behavior of mutant large
T antigens. The drastically reduced replication of some
mutant DNAs in Cos-1 cells could be explained if the ratio
4209
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between wild-type and mutant T antigens in cotransfected
cells were substantially lower with trans-dominant mutants
than with other mutants which were not trans dominant. We
therefore compared these ratios in CV-1 cells cotransfected
by a plasmid encoding wild-type T antigen and different
trans-dominant or non-trans-dominant mutants. No differ-
ences were seen. We also prepared double mutants contain-
ing the relevant mutation of a trans-dominant mutant and
other insertion, deletion, or missense mutations, to deter-
mine whether specific properties of T antigen were required
for trans-dominant activity. In some cases, the double
mutant retained the trans-dominant behavior of its trans-
dominant parent, while in other cases, this behavior was
lost. Taken together, the data suggest that there are multiple
mechanisms of trans dominance and that no single property
of large T antigen is required for trans dominance.
Additional mutants, including several with point muta-
tions in the DNA binding domain of T antigen (40, 55, 56),
were also screened for trans dominance. Some of these
mutants displayed trans dominance, while others did not.
Possible mechanisms of trans dominance are discussed in
terms of these results.
MATERIALS AND METHODS
Plasmid DNAs, cells, and tissue culture. CV-1 cells are a
continuous line of African green monkey kidney cells (31).
Cos-1 cells are an SV40-transformed cell line derived from
CV-1 cells by transformation with an origin-defective mutant
of SV40 (22). Cos-1 cells express SV40 large and small T
antigens constitutively. Murine cell lines expressing various
mutant or wild-type large T antigens were made by cotrans-
fection of BALB/c 3T3 clone A31 cells (69) with mutant or
wild-type SV40 DNAs and pSV2neo, a plasmid containing
the bacterial neomycin phosphotransferase gene under con-
trol of the SV40 early promoter and enhancer (61). After
selection for growth in the presence of 500 ,ug of G418 per
ml, single colonies were subcloned and checked immunohis-
tochemically for expression of T antigen. In some cases,
surviving cells (100 to 300 colonies per plate) were expanded
into pools and used directly; these pools contained more
than 95% T-antigen-positive cells (data not shown). All cells
were cultured in Dulbecco's modified Eagle medium con-
taining 10% newborn calf serum (monkey cells) or 10% fetal
calf serum (FCS) (mouse cells).
pCC2Pa contains the complete SV40 genome cloned into
the EcoRI site of pUC18, in the orientation which places the
BamHI site of pUC18 close to the BamHI site of SV40. p6-1
is a nonreplicative version of pCC2Pa which contains a 6-bp
deletion at the BglI site within the origin of replication (24).
dlA1209 is a deletion mutant lacking 329 bp (nucleotides 4862
to 5191), including the early mRNA start site, the entire first
exon of the large-T-antigen coding region, and the splice
donor site for the large-T mRNA intron (12). pSV2aPAP
contains a human placental alkaline phosphatase gene under
the control of SV40 early promoter (28). Mutants inA2801,
inA2803, inA2815, inA2817, inA2807, inA2809, inA2811, and
inA2827 were described previously (75) and contain 12-nt
linkers inserted at the positions encoding amino acids (aa) 5,
35, 168, 219, 303, 409, 424, and 520, respectively. Mutant
inA2831 contains an in-frame deletion extending from codon
5 to 35 and a linker d(TCGCGATCGCGA) at the deletion
site. Mutants d12441, dlA2411, dlA2432, dlA2433, and
dlA2459 contain small deletions at DdeI sites and produce T
antigens which lack amino acids 105 and 106, 143 to 146, 507
to 510, 587 to 589, and 674 to 708, respectively (70). Fusion
of codons as a result of the deletions resulted in the insertion
of an additional amino acid at the site of the deletion of
mutant dlA2432; the T antigen of dlA2459 contains 3 addi-
tional residues at its C terminus because of a reading
frameshift at the site of the deletion. All mutant genomes
were maintained as recombinant clones in pUC18 with the
same orientation as that of pCC2Pa. The nomenclature used
for deletion and insertion mutants is to list the amino acids
deleted or the site of the insertion in parentheses following
the mutant number. For point mutants, the mutant number is
followed by a designation such as S147T which indicates that
residue 147 of large T is normally serine but was changed to
threonine in that particular mutant.
Plasmid pBS-SV40 and mutants S147T, A149G, S185T,
H187R, and R204K (55, 56) were obtained from Dan Sim-
mons (University of Delaware, Wilmington). The first letter
is the single amino acid code for the amino acid present at
the numbered position in wild-type T antigen; the second
letter is the amino acid which replaces the wild-type residue
in the mutant protein. The parental plasmid for these point
mutants is pBS-SV40, which contains the entire SV40 ge-
nome inserted into the BamHI site of Bluescript (Strata-
gene). Mutant d1A2840 was prepared from pBS-SV40 by
deleting the DNA between the two NdeI sites in the SV40
early region. This deletion removed 1,018 bp, including
sequences extending from the middle of the intron for large
T antigen to a position in the middle of the large-T-antigen
coding region. Since the deletion removes the 3' splice site
for large-T mRNA, the mutant was unable to produce any
large T antigen. Point mutants C-2(K516R) and C-6-2
(N153T) were described previously (22, 23, 40) and were
obtained from Carol Prives (Columbia University, New
York, N.Y.).
Standard techniques for bacterial growth and transfection
(38) and DNA preparation (39) were used.
Construction of double mutants. Double mutants were
constructed by combining appropriate restriction endonucle-
ase fragments of various mutant DNAs, all cloned into the
EcoRI site of pUC18.
Double mutants were constructed from mutants inA2827
(aa520) and in2801(aa5) or dlA2831(aa5-35) by utilizing the
BstXI site in the large-T-antigen intron and the XbaI site in
the polylinker of pUC18. The XbaI-BstXI fragment contains
sequences from pUC18, part of the late region of SV40, the
origin region, the first exon, and part of the intron. The
BstXI-XbaI fragment of inA2827(aaS20) contained the re-
mainder of the intron, the entire second exon of large T
antigen (including the inA2827 mutation), the remainder of
the late region of SV40, and the remainder of pUC18.
Double mutants combining the mutation of inA2827
(aaS20) with dl2441(aalO5-106), SVcT(K128T), or dlA2411
(aal43-146) were made by three-fragment ligations using
BamHI, BstXI, and NdeI sites. The 1,275-bp NdeI-BamHI
fragment of inA2827 extends from the middle of the T-anti-
gen coding region through the site of the insertion of inA2827
to the BamHI site near the end of the VP1 gene. The 951-bp
BstXI-NdeI fragment of d12441, SVcT, inA2815, and
dlA2411 extends from the BstXI site in the middle of the
large-T intron through these mutations located in the proxi-
mal part of the second exon to the NdeI site in the middle of
the large-T-antigen coding region. The 5.7-kb BamHI-BstXI
fragment contains the remaining portions of SV40 and the
complete pUC18 genome. Double mutants containing the
mutations of inA2827(aa520) and inA2815(aal68) were made
by a similar three-fragment ligation strategy using BstHI,
NdeI, and ApaI.
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Double mutants of dlA2459(aa674-708) with d1A2411
(aal43-146), inA2815(aal68), inA2809(aa409), inA2811(aa424),
dlA2432(aaSO9), or inA2827(aaS20) as well as double mutant
inA2827(aa520)/dlA2433(aa587-589) were prepared by three-
fragment ligation using Apal, BstXI, and PstI. ApaI and
BstXI digest each DNA once; there are three PstI sites in all
plasmids used, one in the polylinker region of pUC18, and
two within SV40 sequences. The 946-bp PstI-ApaI fragment
of dlA2459 or dlA2433 extends from the PstI site at nucleo-
tide 3204 of SV40, located upstream of the dlA2433 and
dlA2459 deletions, through the deletions, to the ApaI site
located within the VP1 gene. The 1,555-bp BstXI-PstI frag-
ment extends from the BstXI site within the large-T intron,
through the mutations of dlA2411, inA2815, inA2809,
inA2811, dlA2432, and inA2827, to the PstI site at nucleotide
3204. The 5.43-kbApal-BstXI fragment contains the remain-
ing portions of SV40 and the complete pUC18 genome.
To isolate fragments, DNAs were digested with restriction
enzymes and subjected to electrophoresis on gels of low-
melting-point agarose. The gel slices containing the desired
fragments were excised, melted, and used for ligation either
directly or after purification with GeneClean (Bio 101, La
Jolla, Calif.).
Cell transfection and double staining. CV-1 cells (4 x 105)
in 60-mm-diameter plates were cotransfected with equal
amounts of plasmids of p6-1 and pSV2aPAP (1.0, 2.5, or 7.5
,g of each plasmid) and carrier salmon sperm DNA (to give
a total DNA concentration of 15 ,ug per plate) for 16 h using
the calcium phosphate method (73). At 48 h after transfec-
tion, cells were washed twice with phosphate-buffered saline
(PBS) (1.9 mM NaH2PO4, 8.4 mM Na2HPO4, 150 mM NaCl;
pH 7.4) and fixed with 95% methanol-5% PBS for 10 min at
4°C. The cells were stained for alkaline phosphatase with 240
,ug of fast violet B salt (Sigma) per ml in 0.01% naphthol
AS-MX phosphate alkaline solution (Sigma) for 15 min at
room temperature (28). After the cells were gently washed
with PBS, they were blocked with PBS-4% bovine serum
albumin-10% FCS for 1 h at room temperature and incu-
bated with monoclonal antibody PAb419 supernatant (1:5
dilution) for 25 min at room temperature. The cells were
washed three times with PBS-1% FCS and incubated with a
1/200 dilution of horseradish peroxidase-conjugated goat
anti-mouse immunoglobulin G (Jackson ImmunoResearch
Laboratories, Inc.) for 25 min. The cells were again washed
three times with PBS-1% FCS, incubated in enzyme reac-
tion mixture (50 mM Tris HCl [pH 7.6], 0.6 mg of 3,3'-
diaminobenzidine tetrahydrochloride [Sigma] per ml, 0.03%
H202) for 10 min (27), and examined under the microscope
for cytoplasmic alkaline phosphatase staining (pink) and
nuclear peroxidase staining (brown).
Pulse-labelling and immunoprecipitation. CV-1 cells (4 x
105 cells per 60-mm-diameter plate) were cotransfected with
p6-1 and an SV40 double mutant DNA (2 ,ug of each) and 11jg of salmon sperm carrier DNA by the calcium phosphate
method. After 1, 2, or 3 days, the cells were washed twice
with Tris-buffered saline (25 mM Tris-chloride [pH 7.5], 137
mM NaCl, 5 mM KCI, 0.6 mM Na2HPO4, 0.05 mM MgCl2,
0.7 mM CaCl2) and incubated for 1 h at 37°C in 2 ml of
Dulbecco's modified Eagle medium lacking methionine and
containing 2% dialyzed FCS. The medium was removed and
the cells were labelled for 1 h with 100 ,uCi of [35S]methio-
nine (Dupont, NEN Research Products, Boston, Mass.) in
0.7 ml of Dulbecco's modified Eagle medium lacking methi-
onine and containing 2% dialyzed FCS. Nuclear extracts
were prepared and immunoprecipitated with PAb419 mono-
clonal antibody as described previously (75). Antibody
PAb419 was present in excess of large T antigen (data not
shown).
Analysis of viral DNA replication. Cos-1 cells were trans-
fected with wild-type or mutant DNAs by the DEAE-
dextran method (72) and harvested by the Hirt method as
described previously (75). The low-molecular-weight DNAs
were digested with MboI and fractionated on a 1.5% agarose
gel. The input plasmids, isolated from bacterial cultures, are
methylated on 5'-GmATC-3' sequences and therefore were
resistant to MboI digestion. Unmethylated progeny viral
DNAs are sensitive to digestion by MboI and could therefore
be separated from the input DNAs by electrophoresis. The
DNAs were then transferred to Nytran nylon membranes
iSchleicher & Schuell, Inc., Keene, N.H.), probed with
2P-labelled pCC2Pa DNA (labelled by nick translation), and
visualized by autoradiography. To monitor the efficiency and
uniformity of transfer of DNA to nylon, Hinfi-digested
pCC2Pa DNA was included in flanking lanes.
RESULTS
In our original studies of trans-dominant mutants which
affected viral DNA replication, we discussed possible mech-
anisms that could permit mutant T antigens to interfere with
the replicative activities of wild-type T antigen. trans-dom-
inant mutant T antigens could bind to the SV40 origin of
replication and block or hinder binding by wild-type T
antigen. Alternatively, trans-dominant mutant T antigens,
but not other T antigens, might be able to sequester some
limiting host cellular factors required for viral DNA replica-
tion. Finally, trans-dominant mutant T antigens, but not
other T antigens, might be able to sequester wild-type T
antigen in inactive mixed heterooligomers.
In these models, the actual amounts of mutant and wild-
type T antigen and their ratios could be important factors in
determining how much viral DNA replication occurred.
Several properties of large T antigen could result in different
ratios of mutant T antigen to wild-type T antigen within
cotransfected cells. First, large T antigen, through binding to
site I within the SV40 origin region, represses early tran-
scription (50). T antigen also activates transcription from
many viral and cellular promoters. The ability of different
mutant T antigens to autoregulate viral early transcription,
to transactivate early transcription, or some combination of
these could be better or worse than that of wild-type T
antigen. Most of the mutant T antigens that we have exam-
ined have a stability similar to that of wild-type T in stably
transformed rodent cells (75). However, differences in sta-
bility would clearly affect the amounts and ratios of mutant
T antigen to wild-type T antigen in transiently transfected
Cos-1 and CV-1 cells. We decided to examine these ratios
under conditions similar to those in which interference with
replication occurred.
Coexpression of mutant and wild-type T antigens in CV-1
cells. In our previous report, SV40 DNAs encoding trans-
dominant mutant T antigens replicated poorly when trans-
fected into Cos-1 cells because of interference by mutant T
antigens. By cotransfecting CV-1 cells with an origin-defec-
tive plasmid encoding wild-type T antigen and a replication-
competent plasmid encoding mutant T antigen, we saw that
the level of interference with viral DNA replication by
trans-dominant mutants was equivalent to that seen previ-
ously with Cos-1 cells (75). Cos-1 cells were not suitable for
analyzing the ratios of mutant T antigen to wild-type T
antigen, since only a modest fraction of cells can be trans-
fected with viral DNA. The expression of wild-type T
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TABLE 1. Efficiency of cotransfection in CV1 cells
Amt (jig) of DNA transfected" No. (%) of cells with staining pattern"
SV40 pSV2aPAP Salmon sperm T+ pap- T pap+ T- pap+ T+ pap? T? pap-
7.5 7.5 0 28 (12) 192 (79) 12 (5) 8 (3) 2 (1)
2.5 2.5 10 61 (22) 190 (69) 4 (1) 20 (7) 0 (0)
1.( 1.0 13 37 (14) 211 (80) 2 (1) 13 (5) 0 (0)
CV-1 cells (4 x 1(5 cells per 60-mm-diameter plate) were transfected with the indicated DNA by the calcium phosphate method.
"The cells were stained for alkaline phosphatase, incubated with PAb419, and stained for horseradish peroxidase. Seven randomly chosen fields from each
stained plate were scored under the microscope. T' pap' cells were positive for both brown nuclear horseradish peroxidase (HRP) staining and pink cytoplasmic
placental alkaline phosphatase (PAP) staining. T+ pap- and T- pap+ cells were positive for either PAP or HRP staining, respectively. Some cells (T+ pap? and
T? pap') lost either cytoplasm or nuclei during staining. In all the plates examined, about 50% of the cells showed staining for PAP, HRP, or both.
antigen alone in all nontransfected Cos-1 cells created too
high a background to permit us to determine accurately
whether trans-dominant mutants and non-trans-dominant
mutants affected the amounts of mutant and wild-type T
antigen and their ratios differently.
To examine the levels of wild-type and mutant T antigens
in cells expressing both proteins, we used CV-1 cells. We
wished to know what fraction of cells that received one type
of plasmid would also take up and express a second plasmid.
CV-1 cells were cotransfected with p6-1 (defective origin,
encoding wild-type T antigen) and pSV2aPAP, encoding
human placental alkaline phosphatase. Two days after trans-
fection, the cells were stained for alkaline phosphatase and
cells expressing T antigen were identified immunohisto-
chemically. The results (Table 1) indicated that 75 to 90% of
the cells positive for T antigen also stained positive for
alkaline phosphatase and that more than 90% of the cells
positive for alkaline phosphatase also expressed T antigen.
Cotransfected CV-1 cells were therefore used to study the
effect of mutant large T antigens on the expression of
wild-type T antigen in the same cells.
Several mutants were chosen for this study on the basis of
the location of their mutations within the gene for T antigen
and the stabilities of the mutant T antigens. dlA2411(aal43-
146) and dlA2432(aa509) have small in-frame deletions.
Mutants inA2815(aal68), inA2809(aa409), inA2811(aa424),
and inA2827(aa520) are linker insertion mutants with a 12-bp
oligonucleotide inserted at the positions indicated. Mutants
d/A2411(aal43-146) and inA2815(aal68) are defective in both
site I and site II binding, while the other mutants showed
normal binding to viral DNA (76). dlA2411(aal43-146),
dlA2432(aa509), and inA2827(aa520) are trans-dominant mu-
tants, whereas inA2815(aal68), inA2809(aa409), and
inA2811(aa424) are not (75). In order to distinguish these
mutant T antigens from wild-type T antigen, double mutants
were made by combining each of these mutants with the
mutation of dlA2459(aa674-708). dIA2459 encodes a trun-
cated T antigen lacking residues 674 to 708, and its smaller T
antigen can be separated electrophoretically from wild-type
T antigen. The C terminus of T antigen provides host range
and adenovirus helper function, and dIA2459 mutant T
antigen is fully functional in viral DNA replication (11, 13).
These double mutant T antigens interfered with viral DNA
replication in a manner similar to that of the full-length
mutant T antigens (data not shown).
CV-1 cells were cotransfected with origin-defective p6-1
DNA and origin-containing DNA of various double mutant
DNAs. Since none of the mutant T antigens are replication
competent, there should be no viral DNA replication in cells
which received only p6-1 (defective origin, encoding wild-
type T antigen) or a double mutant plasmid (functional
origin, replication-defective mutant T antigen) alone. This
cotransfection procedure ensured that viral DNA replication
would occur only in cells transfected by both plasmids.
Mutant dlA1209 was used as a control because it contains a
near-full-length SV40 DNA with a functional origin and does
not express T antigen (12). Cells were pulse-labelled for 1 h
with [35S]methionine on days 1, 2, and 3 following transfec-
tion. After the cells were labelled, extracts were prepared
and immunoprecipitated with anti-T antigen monoclonal
antibody PAb419, and the proteins were fractionated on
sodium dodecyl sulfate-polyacrylamide gels (Fig. 1). In all
cases, the upper band represents full-length wild-type T
antigen and the lower bands represent mutant T antigens
lacking the normal carboxy terminus. In the absence of any
mutant T antigen (p6-1 plus dlA1209), the synthesis of
wild-type T antigen was the greatest on day 1 and was
reduced to a very low level by day 3. Previous experiments
(75) suggested that little input plasmid remains within cells
by day 3.
In cells cotransfected by p6-1 and double mutants, the
pattern of wild-type expression was similar to that seen with
p6-1 and dlA1209. The pattern of mutant T-antigen expres-
sion was similar or identical with all mutants examined.
There was slightly less mutant T antigen than wild-type T
antigen produced on the first day. By the second day, the
amount of mutant T produced equalled or slightly exceeded
the amount of wild-type T, reflecting reduced copy number
of wild-type DNA and increased copy number of each
mutant genome. By the third day, mutant T production
exceeded wild-type T-antigen production in all cases. None
of the mutant T antigens had any significant effects on the
expression of wild-type T antigen, regardless of whether or
not they were trans dominant. We conclude that the trans-
dominant behavior cannot be explained by differential ef-
fects on the levels of wild-type T or on the ratio of mutant T
antigen to wild-type T antigen.
Replication of double mutants in Cos-I cells. One possible
mechanism of trans dominance involves occupancy of the
SV40 origin region by trans-dominant T antigens, preventing
wild-type T from gaining access to and catalyzing the repli-
cation of the viral DNA. This possibility was investigated by
determining whether a double mutant containing the
inA2827(aa520) mutation and a mutation in the DNA binding
domain would retain trans dominance. We also wondered
whether trans dominance would be affected by combining
the inA2827 trans-dominant mutation with mutations affect-
ing other properties of T antigen.
We therefore prepared double mutants with the strongest
trans-dominant mutant, inA2827, and mutants defective for
other properties of T antigen. The other mutants used are
shown in Fig. 2. The double mutant SV40 DNAs were
J. VIROL.
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FIG. 1. Coexpression of mutant and wild-type T antigens in CV-1 cells. CV-1 cells were transfected with origin-defective plasmid encoding
wild-type T antigen and origin-plus DNAs encoding mutant T antigen as described in Materials and Methods. The numbers of days after
transfection are indicated over the lanes. The cells were pulse-labelled with [35S]methionine for 1 h. Nuclear extracts were prepared,
immunoprecipitated with monoclonal antibody PAb419, and analyzed by electrophoresis on sodium dodecyl sulfate-7.5% polyacrylamide
gels. The positions of molecular weight markers are indicated at the left.
transfected into Cos-1 cells, and viral DNAs were isolated 0,
1, 3, and 5 days after transfection. These were digested with
AlboI restriction endonuclease to distinguish input DNA
(resistant to MboI due to methylation in Escherichia coli)
from progeny DNA (sensitive to MboI digestion), fraction-
ated electrophoretically, and analyzed by Southern blotting
(60), as shown in Fig. 3. The analyses of many of these
mutants were repeated in additional experiments and iden-
tical results were obtained.
The 329-bp deletion of dlA1209 removes the early mRNA
cap site, the first exon of large T antigen, and the large-T-
antigen splice donor site. Several monoclonal antibodies to T
antigen failed to detect cross-reacting material by either
immunoprecipitation or immunofluorescence in cells trans-
fected with dlA1209. Therefore, replication of this plasmid in
Cos-1 cells should reflect only the activity of the endogenous
T antigen, which is constitutively expressed in Cos-1 cells.
Mutant viral DNA replication in inA2827(aa520)-transfected
RB N.L.S.
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DNA pol cc DNA
binding Binding
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FIG. 2. Map of mutations used to construct double mutants of
inA2827 and other T-antigen mutants. The two exons of the SV40
large-T-antigen coding region are shown as two rectangular boxes
with amino acid numbers listed above. The DNA polymerase (pol) at
binding domain, retinoblastoma protein (RB) binding site, nuclear
localization signal (N.L.S.), DNA binding domain, ATP binding and
ATPase domain, the sequences required for helicase activity, and
the region encoding host range and adenovirus (Adeno) helper
functions are indicated at the top of the figure. The circled Zn
represents the zinc finger motif. N and C refer to the amino and
carboxyl termini, respectively. Second mutations are indicated at
the bottom with point, linker insertion, and small deletion mutations
shown as dots and larger truncations shown as horizontal bars.
cells was about 10% of the level seen in cells transfected with
dlA1209.
inA2815(aal68) encodes a mutant T antigen which does
not bind to the SV40 origin. inA2815 DNA replicated as well
as dlA1209 (Fig. 3B), indicating that inA2815 T antigen did
not interfere with DNA replication. The double mutant
inA2815/inA2827 T antigen also did not interfere with DNA
replication, suggesting that DNA binding may be required
for the strong trans dominance of inA2827(aa520), although
other explanations are also possible (discussed below). Both
inA2815 and inA2827 encode stable T antigens, and the
double mutant T antigen had similar stability (data not
shown); furthermore, this double mutant protein appeared to
have a relatively normal conformation because it, like both
parents, showed equivalent and strong reactivity with almost
all members of a large panel of anti-T-antigen monoclonal
antibodies tested (2).
The mutant T antigen encoded by dlA2411(aal43-146)
does not bind to the SV40 origin. DNA replication in cells
transfected with dlA2411 was considerably less than in cells
transfected with dlA1209 but greater than in inA2827-trans-
fected cells (Fig. 3A). dlA2411 therefore has a moderate
trans-dominant effect on viral DNA replication. A double
mutant combining dlA2411 and the strongly trans-dominant
inA2827(aa520) was examined. Viral DNA replication in
cells transfected with dlA2411/inA2827 was intermediate
between that seen in cells transfected with each of the two
parental plasmids. In other experiments (data not shown),
replication in cells transfected with dlA2411/inA2827 more
closely approximates the level of replication in dlA2411-
transfected cells.
dl2441(aalO5-106) contains a small in-frame deletion
within the binding site for the retinoblastoma susceptibility
protein, p105Rb. This mutant T antigen is less able than
wild-type T to form complexes with p105Rb but was able to
form a reduced level of T-p105Rb complexes (77). This
nfttant is able to immortalize primary mouse embryo fibro-
blast cells but does not cause full transformation of those
cells (67). Viral DNA replication in dl2441/inA2827-contain-
ing cells was similar to that in inA2827-transfected cells (Fig.
3A), suggesting that wild-type levels of p105 Rb binding were
not important for the trans dominance of inA2827 T antigen.
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FIG. 3. Replication of double mutants in Cos-1 cells. Cos-1 cells were transfected with DNAs of the double mutants, and low-molecular-
weight DNA was harvested 0, 1, 3, and 5 days after transfection. After digestion with MboI, the DNAs were fractionated by electrophoresis
on 1.5% agarose gels, transferred to nylon membranes, and hybridized to a 32P-labelled probe specific for SV40 sequences. To monitor the
efficiency and uniformity of transfer of DNA to nylon, Hinfl-digested pCC2Pa DNA was included in flanking lanes. The data presented in
panel A come from two experiments which contained different mutants and the same controls (dlA1209 for endogenous wild-type T activity
and inA2827 for strong trans dominance). The relative amounts of replicated viral DNA in the controls were the same in each experiment,
allowing direct comparison of the data from each experiment. The mutants in panel B were analyzed separately. The presence of extra MboI
sites located at different positions in mutant genomes caused some mutants to have fragments of different sizes.
Introducing the mutations of in2801(aa5), dlA2831(aa5-35),
or dlA2459(aa674-708) into inA2827(aa520) did not eliminate
or significantly reduce the trans-dominant behavior of
inA2827 T antigen. Therefore, these amino acids near the
amino and carboxy termini of the inA2827 T antigen ap-
peared to play no role in the trans-dominant interference.
SVcT(K128T) T antigen contains a point mutation (35)
within the nuclear localization signal, and the mutant protein
is not transported efficiently to the nucleus. There was a
similar amount of viral DNA replication in SVcT-transfected
cells and dlA1209-transfected cells. Viral DNA replication in
cells transfected by the SVcT/inA2827 double mutant was
slightly less than in cells transfected with the SVcT single
mutant but considerably more than viral DNA replication in
cells transfected with inA2827(aa520) (Fig. 3A). This double
mutant T antigen resembled SVcT T antigen in being local-
ized to the cytoplasm, as determined by immunofluores-
cence staining (data not shown). This suggests that nuclear
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FIG. 4. Stabilities of mutant T antigens in CV-1 cells. CV-1 cells
were transfected with plasmids encoding wild-type or mutant T
antigens. Two days later, cells were pulse-labelled for 1 h with
[35S]methionine and lysed either immediately (O h) or after culturing
in complete medium for 5 or 17 h. Nuclear extracts were immuno-
precipitated with PAb419 and analyzed by electrophoresis on a
sodium dodecyl sulfate-7.5% polyacrylamide gel. The positions of
molecular weight markers are shown at the left. T Ag, T antigen.
localization of a mutant T antigen may be necessary for
maximum trans dominance. The fact that DNA replication
caused by SVcT/inA2827 T antigen was less than that caused
by SVcT T antigen probably reflects the presence within the
nucleus of a small amount of this double mutant T antigen,
leading to some interference with replication catalyzed by
wild-type T antigen. Retention of some wild-type T antigen
in the cytoplasm through oligomerization with the double
mutant T antigen is also possible.
Another second mutation which completely reversed the
trans-dominant behavior of inA2827(aaS20) T antigen was
dlA2433(aa587-589) (Fig. 3A). dlA2433(aa587-589) contains a
small in-frame deletion and the mutant protein does not bind
p53 (67, 71, 74). There are several possible explanations for
this finding. Since inA2827(aaS20) T antigen binds p53 while
dlA2433(aa587-589) does not, p53 binding might be essential
for a T antigen to show trans-dominant interference. A
related possibility is that trans dominance reflects interac-
tions between mutant T antigen and either wild-type T
antigen or some host factor other than p53 but that the loss
of residues 587 to 589 alters the conformation of the double
mutant protein, affecting other protein-protein interactions.
Instability of the double mutant T antigen could also prevent
its interfering with viral DNA replication.
To examine the last possibility, the stabilities of mutant T
antigens were examined by labelling cells for 1 h with
[35S]methionine followed by chase periods of S and 17 h. The
data show (Fig. 4) that inA2827(aaS20) T antigen was as
stable as wild-type T antigen while dlA2433(aa587-589) T
antigen was much less stable, as reported previously (75).
The inA2827/dlA2433 T antigen was as unstable as dlA2433
T antigen. Therefore, the failure of this double mutant T
antigen to interfere with wild-type T antigen in viral DNA
replication can be explained by its instability.
trans dominance of additional SV40 mutants. We examined
a number of additional mutants for their ability to interfere
trans dominantly with SV40 DNA replication. These mu-
tants included several mutants with conservative amino acid
substitutions in the DNA binding domain (S147T, A149G,
S185T, H187R, and R204K) (55, 56) and one with an inser-
tion [inA2817(aa215)] in this region. All five point mutants
were replication defective and differed widely in their ability
to bind DNA and in helicase activity (55, 56). Mutant
inA2817(aa215) is replication defective but retains wild-type
DNA binding activity. We also examined two mutants
cloned from CV-1 cells transformed by replication-defective
SV40 genomes (22, 23). These mutants had been shown
previously to be trans dominant in vitro (63) but had not
been studied in vivo. Mutant C-6-2(N153T) is defective for
DNA binding, while mutant C-2(K516R) retains normal
DNA binding but is defective for ATPase activity (40).
Mutants S147T, A149G, S185T, H187R, and R204K were
not trans dominant (Fig. 5). Because the genomes of mutants
S147T, A149G, S185T, H187R, and R204K were prepared in
a plasmid background different from those of our other
mutants, we used as a control for these studies a new
plasmid, dlA2840, in which the 1,018-bp small NdeI frag-
ment (nucleotides 3808 to 4826) was deleted from a wild-type
SV40 genome inserted into the same plasmid background as
these DNA binding domain point mutants. This plasmid
cannot encode a large T antigen. In Cos-1 cells, its replica-
tion level was similar to that of dlA1209, the control plasmid
for study of deletion and linker insertion mutants cloned into
pUC18. Mutant inA2817(aa215) was strongly trans domi-
nant. Mutant C-6-2 was moderately trans dominant, while
mutant C-2 was strongly trans dominant (Fig. 5).
DISCUSSION
trans-dominant or dominant-negative mutants have been
described in many systems. In prokaryotes, dominant neg-
ative lac repressor mutants form inactive heterotetramers
with wild-type protein (43). In eukaryotes, several dominant
negative mutants of transcription factors or transactivating
proteins were found to inhibit transcriptional activation by
wild-type protein. Mutant c-Jun proteins with point and
deletion mutations in the basic domain were able to form
heterodimers with Fos protein and suppress the wild-type
c-Jun/Fos DNA binding activity and transcriptional activa-
tion function (48). Heterodimers were formed between wild-
type and dominant-negative mutants of herpes simplex virus
type 1 transcriptional regulatory protein ICP4. These hetero-
dimers retained DNA binding activity but failed to activate
transcription (54). Deletion of the acidic transcriptional
activation domain of another herpes simplex virus type 1
transcriptional regulatory protein, VP16, and the activating
region II of human immunodeficiency virus type 1 trans-
activator protein, Tat, also created dominant negative mu-
tants. Presumably the mutant proteins competed with wild-
type proteins for binding to a cellular DNA-binding protein
but failed to activate because they lack the activating domain
(20, 26). Point and deletion mutations in one of the functional
domains of human immunodeficiency virus type 1 Rev
protein and the analog protein, Rex, of human T-cell leuke-
mia virus type I resulted in trans-dominant suppression of
sequence-specific nuclear export of incompletely spliced
viral mRNAs (37, 49). Finally, adeno-associated virus con-
tains a multifunctional regulatory gene, rep, required for
viral DNA replication and regulation of viral gene expres-
sion. A point mutation in the nucleotide binding site in the
Rep protein resulted in overproduction of the protein which
was able to inhibit in trans wild-type adeno-associated virus
--
----,
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FIG. 5. Analysis of additional mutants for trans dominance. Cos-1 cells were transfected with mutant DNAs, and the low-molecular-
weight DNA was harvested 0, 3, and 5 days after transfection. After digestion with MboI, the DNAs were fractionated by electrophoresis on
1.5% agarose gels, transferred to nylon membranes, and hybridized to a 32P-labelled probe specific for SV40 sequences. dlA1209 and dlA2840
were controls for the level of replication mediated by endogenous T, and inA2827 was included for comparison. Because of differences among
the mutant genomes and plasmid backgrounds, the MboI digestion patterns were not identical.
DNA replication (9). This last situation closely resembles the
trans dominance we have been studying and could occur by
similar mechanisms.
SV40 large T antigen is the only viral protein required for
viral DNA replication. It binds specifically to the SV40
origin of replication, nonspecifically to double- and single-
stranded DNA; it interacts specifically with p53 and cellular
DNA polymerase a. and perhaps also with other cellular
replication factors, and it forms oligomers. An understand-
ing of the mechanisms of interference with viral DNA
replication by trans-dominant mutant T antigens could pro-
vide important insights into these processes. trans-dominant
interference with viral DNA replication has been reported
for SV40 (19) and polyomavirus (45). In both systems, the
trans-dominant interfering T antigens possessed mutations
which affected their ATPase domains. We showed that
mutants in other regions of SV40 large T antigen could also
inhibit viral DNA replication (75). Stillman et al. (63),
showed that some mutant T antigen could inhibit SV40 viral
DNA replication in vitro, and the data presented above
indicate that two of these mutants, C-6-2(N153T) and
C-2(K516R), were also trans dominant in vivo.
In this report, we have extended our previous study of
trans-dominant mutants (75) in an attempt to learn more
about mechanisms of the interference. We first eliminated
the possibility that trans-dominant mutant T antigens acted
by suppressing the expression of the wild-type T antigen.
Large T antigen activates viral and cellular genes and
autoregulates its own expression. However, the presence of
various mutant T antigens in the same cells as wild-type T
had no significant effects on wild-type T antigen synthesis,
regardless of whether the mutants were trans dominant or
not. The conditions used to examine T-antigen expression
were exactly the same as those used to demonstrate the
ability of trans-dominant mutants to interfere with viral
DNA replication in CV-1 cells. Since 75 to 90% of trans-
fected cells were cotransfected (Table 1), it should have been
relatively easy to detect any significant changes in wild-type
T antigen expression caused only by trans-dominant mu-
tants. Although the amount of replication of the various
mutant DNAs varied considerably from one mutant to
another (75), the synthesis rates of different mutant T
antigens showed little variation, even after 3 days. This may
reflect autoregulation of the early promoter by T antigen.
One concern about these experiments was that homolo-
gous recombination would occur between the replication-
defective plasmid encoding wild-type T antigen and the
replication-competent plasmid encoding mutant T antigen,
making interpretation of the results difficult. The replication-
defective plasmid p6-1 has a single lesion within the origin of
replication. The plasmids encoding mutant T antigens in this
experiment were double mutants. Each contained two le-
sions, the deletion of dlA2459(aa674-708) and a second
mutation located at various sites within the T-antigen gene.
Recombination would generate a variety of recombinants,
including replication-competent plasmids encoding wild-
type T, and plasmids encoding full-length forms of mutant T
antigens and truncated forms of wild-type T antigen. Such
replication-competent plasmids would then have replicated
in the presence of wild-type T antigen, and this would be
expected to lead to an increase in the amount of full-length T
antigen at later times after infection. The fact that nearly
identical patterns of wild-type and mutant T-antigen synthe-
sis were seen with trans-dominant and non-trans-dominant
mutants and with mutants with lesions both nearest to
[dlA2411(aal43-146)] and furthest from [inA2827(aa520)] the
origin region mutation of p6-1 argues against recombination
being a significant factor in this experiment.
We next analyzed a series of double mutants in order to
find out whether there might be some specific functions of T
antigen required for trans dominance to occur. We chose to
prepare a set of double mutants which contained the
inA2827(aa520) mutation because it is the strongest trans-
dominant mutant; its mutation is located in the ATPase
domain, where a majority of previously described trans-
dominant mutations map. The trans dominance of
inA2827(aa520) was reversed by the DNA-binding-defective
mutation of inA2815(aal68) and by the mutation of
dlA2433(aa587-589). However, the loss of trans dominance
in dIA2433/inA2827 probably can be fully explained by the
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fact that this double mutant protein was extremely unstable.
In contrast, the T antigens of inA2815(aaI68), inA2827
(aa520), and inA2815/inA2827 were all as stable as wild-type
T antigen. One possible explanation for loss of trans domi-
nance in the inA2815/inA2827 double mutant is that the
trans-dominant behavior of inA2827 T antigen requires that
it bind to DNA. Alternatively, DNA binding per se may not
be required, but an intact DNA binding domain may be
needed for the inA2827 T antigen to interact with wild-type
T antigen or with some host cell factor.
Clearly, DNA binding and a wild-type DNA binding
domain are not general requirements for trans-dominant T
antigens, since DNA binding domain mutants dlA2411
(aal43-146) and C-6-2(N153T) both displayed moderate trans
dominance. Both of these mutant genomes replicated to a
greater extent in Cos-1 cells than did inA2827(aa520) DNA.
We constructed a double mutant from the DNA binding
mutant dlA2411(aal43-146) and inA2827(aa520). The double
mutant was also trans dominant, to about the same extent as
dlA2411(aal43-146) and to a lesser extent than inA2827
(aa520). If inA2827(aa520) interferes with wild-type T anti-
gen's replicative ability by binding to DNA, d/A2411(aa143-
146) would have to use a different mechanism of trans
dominance, and the double mutant, dlA2411/inA2827, would
have to be using dlA2411's mechanism. Alternatively, if
protein-protein interactions underlie trans-dominant inter-
ference, the dlA2411/inA2827 and inA2815/inA2827 T anti-
gens could differ quantitatively in the strength of their
interactions with other proteins.
No effect on trans dominance was seen when mutations
within the retinoblastoma-binding domain, the N-terminal 35
amino acids, or the C-terminal 35 amino acids were com-
bined with the mutation of inA2827. Interestingly, a muta-
tion in the nuclear localization signal, SVcT(K128T), com-
bined with inA2827 substantially reduced the degree of
interference. SVcT T antigen localizes to the cytoplasm, as
does the double mutant inA2827/SVcT (unpublished results).
The fact that inA2827/SVcT allowed more DNA replication
than inA2827 alone indicates that the strong dominant neg-
ative effect of inA2827(aa520) T antigen on wild-type repli-
cative function probably requires nuclear location of the
interfering T antigen. Were binding to viral DNA important
for its trans dominance, this would be the case. This finding
is also consistent with inA2827 interfering by sequestering a
cellular nuclear factor in an inactive complex. It has been
reported that SVcT T antigen inhibits the nuclear localiza-
tion of wild-type T antigen in Cos-1 cells (35), presumably by
forming heterooligomers with wild-type T. The data pre-
sented here show that Cos-1 cells transfected by either SVcT
or inA2827/SVcT contain sufficient wild-type T in the nu-
cleus to permit a substantial amount of viral DNA replica-
tion. Furthermore, the result that inA2827/SVcT showed
less replication than SVcT did indicates that either a small
percentage of inA2827/SVcT is able to reach the nucleus to
cause trans dominance or that inA2827 can carry out its
dominant negative effect on DNA replication to a lesser
degree while it is localized in the cytoplasm.
We also screened a number of additional mutants for trans
dominance. These included five mutants with conservative
amino acid substitutions in the DNA binding domain. Inter-
estingly, none of them showed any interference. These DNA
binding domain mutants vary considerably in helicase activ-
ity and in both specific and nonspecific DNA binding (55,
56). Among other mutants examined with lesions in the DNA
binding domain, mutants C-6-2(N153T) and dlA2411(aal43-
146) were moderately trans dominant, dlA2815(aal68) was
not trans dominant and mutant inA2817(aa217) was strongly
transdominant. We see no pattern relating these activities of
T antigen to trans dominance. All of these mutant T antigens
have approximately the same stability as wild-type T anti-
gen. Thus, there is no simple model that explains the
patterns of trans dominance we have seen. Rather, our data
suggest that multiple mechanisms are involved.
Oligomerization may be central to the dominant-negative
behavior of some mutant T antigens. Perhaps only tr)als-
dominant mutant T antigens are able to form heterooligo-
mers with wild-type T. Alternatively, both trans-dominant
and non-trans-dominant mutants might be able to form
heterooligomers with wild-type T antigen, but the properties
of heterooligomers between wild-type and tran.s-dominant
mutant T antigens might be distinctly different from the
properties of heterooligomers between wild-type and non-
trans-dominant mutant T antigens. In the presence of ATP,
T antigen assembles in hexamers (41, 46). DNA is not
required but stimulates hexamer formation cooperatively
(46). This means that hexamer formation does not require an
intact DNA binding domain. Some tran.s-dominant mutants
may sequester wild-type T antigen in mixed hexamers, thus
reducing the amount of wild-typc T antigcn availablc for
replication. Other mutant T antigens might assemble on
SV40 DNA into hexamers containing wild-type and mutant
subunits; it is not known whether there are any conditions
under which such mixed hexamers, formed from wild-typc
and mutant subunits, would be active in DNA replication.
We reported previously that a DNA-binding-defective T
antigen could not complement an ATPase-defective T anti-
gen to restore viral DNA replication (70). However, othcr
combinations of various mutants might restore this activity,
and hexamers containing wild-type T antigen and T antigcns
encoded by some mutants might retain partial or full activity
for DNA replication.
Perhaps mutants with conservative amino acid substitu-
tions in the DNA binding domain retain full ability to
oligomerize at the origin of replication, and oligomers con-
taining wild-type and mutant subunits might retain normal
activity for viral DNA replication. Mixed oligomers between
T antigens which showed moderate interference with viral
DNA replication [dlA2411(aal43-146) and C-6-2(N153T)I
might retain some replicative activity but less than that of the
wild type. Finally, mutants which are strongly trans domi-
nant might form mixed oligomers totally defective for viral
DNA replication. We have recently begun to examine the
ability of mutant T antigens to oligomerize and to form
heterooligomers with wild-type T antigen.
ATP-binding and ATPase activity might also play roles in
some mechanisms of trans dominance. In an oligomer,
binding of ATP to one T antigen molecule appears to inducc
allosteric changes in other T-antigen molecules (4, 46).
Although we have not analyzed ATP binding by all mutant T
antigens, many have mutations in the ATP binding or
ATPase domain. The T antigens of mutants dlA2433(aa587-
589), d/A2432(aa509), and d/A2462(aa507-510) are known to
be defective for ATPase activity, while trans-dominant
mutant dlA2411(aal43-146) T antigen showed wild-type
ATPase activity (14). Altered ability to interact with ATP
could result in the formation of hexamers unable to undergo
important ATP-mediated, allosteric changes. Some mutant T
antigens are likely to bind ATP normally but be defective for
ATPase activity, since the latter activity requires a larger
portion of T antigen than the former. Such ATPase-defective
mutants might form mixed hexamers bound to SV40 DNA,
and ATP binding might bring about the normal allosteric
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changes; however, inability to hydrolyze ATP could result in
such mixed hexamers remaining bound to SV40 DNA but
unable to catalyze critical steps requiring ATP hydrolysis.
Each step performed by T antigen in DNA replication is a
potential step at which trans-dominant interference could
occur. The use of in vitro SV40 DNA replication systems has
added substantially to our understanding of viral DNA
replication in recent years. These systems offer the best
prospect for further elucidating the mechanisms by which
mutant T antigens interfere with the replication activities of
wild-type T antigen.
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